Results 101 to 110 of about 186 (117)

Improving immunotherapy outcomes with anti-angiogenic treatments and vice versa

Nature Reviews Clinical Oncology, 2018
Kabir A Khan, Robert S Kerbel
exaly  

Anti-CRISPR: discovery, mechanism and function

Nature Reviews Microbiology, 2017
April Pawluk, Alan R Davidson, Karen L Maxwell   +2 more
exaly  

New avenues for anti-epileptic drug discovery and development

Nature Reviews Drug Discovery, 2013
Wolfgang Löscher
exaly  

Distinct Immune Cell Populations Define Response to Anti-PD-1 Monotherapy and Anti-PD-1/Anti-CTLA-4 Combined Therapy

Cancer Cell, 2019
Tuba N Gide, Camelia Quek, Alexander M Menzies   +2 more
exaly  

Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination

Nature Reviews Clinical Oncology, 2016
Celine Boutros, Ahmad A Tarhini, Olivier Lambotte   +2 more
exaly  

Bacterial Retrons Function In Anti-Phage Defense

Cell, 2020
Adi Millman, Aude Bernheim, Avigail Stokar-Avihail   +2 more
exaly  

Anti-virulence strategies to combat bacteria-mediated disease

Nature Reviews Drug Discovery, 2010
Vanessa Sperandio
exaly  

The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease

Nature Reviews Immunology, 2011
Michael Gleeson, Nicolette C Bishop, David J Stensel   +2 more
exaly  

Anti-infective monoclonal antibodies: perils and promise of development

Nature Reviews Drug Discovery, 2006
Janice M Reichert
exaly  

Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy

Cell, 2017
Antoni Ribas, Reinhard Dummer, Igor Puzanov   +2 more
exaly